Picture of Lunai Bioworks logo

LNAI — Lunai Bioworks News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Enochian Biosciences Announces Acquisition Of Exclusive License For Potential Pan-Coronavirus And Pan-Influenza Inhaled Treatment And Prevention Technology

June 21 (Reuters) - Enochian Biosciences Inc  ENOB.O :
    * ENOCHIAN BIOSCIENCES ANNOUNCES ACQUISITION OF EXCLUSIVE
LICENSE
FOR POTENTIAL PAN-CORONAVIRUS AND PAN-INFLUENZA INHALED
TREATMENT AND PREVENTION TECHNOLOGY
    * ENOCHIAN BIOSCIENCES INC - REQUEST FOR A PRE-INVESTIGATOR
NEW
DRUG MEETING FOR COVID-19 TREATMENT WILL BE SUBMITTED TO FDA IN
NEAR TERM

Source text for Eikon:  ID:nGNXbGpCxZ 
Further company coverage:  ENOB.O 

 ((reuters.briefs@thomsonreuters.com;))

Recent news on Lunai Bioworks

See all news